Autopsy report · NCT02673684

Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use

“Lost funding from sponsor”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 4 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Defense and Veterans Center for Integrative Pain Management

Sponsor type

University, hospital or other

Conditions

Pain (Visceral, Somatic, or Neuropathic)

Interventions

Experimental NSS; Sham NSS

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
  “Sponsor lost funding” (98% match in meaning)
• Mepolizumab for Eosinophilic Fasciitis
  “Funding lost from Sponsor.” (93% match in meaning)
• Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
  “Loss of Financial Sponsor” (87% match in meaning)
• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (86% match in meaning)
• 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study
  “Sponsor withdrew Funding” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.